SCHEMBL805199

SCHEMBL805199

CN[C@H](Cc1ccc(F)cc1)C(=O)O

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.56
ACE P12821 2/20 0.54
CA2 P00918 1/20 0.51
MME P08473 2/20 0.49
GPR34 Q9UPC5 2/20 0.48
CPA1 P15085 2/20 0.47
ACE2 Q9BYF1 1/20 0.47
FOLH1 Q04609 1/20 0.46
CA12 O43570 1/20 0.46
CA7 P43166 1/20 0.46
CA9 Q16790 1/20 0.46
CA14 Q9ULX7 1/20 0.46
POLB P06746 1/20 0.46
KMT2A Q03164 1/20 0.46
NOS3 P29474 1/20 0.46
NOS1 P29475 1/20 0.46
NOS2 P35228 1/20 0.46
PPARG P37231 1/20 0.45
CTSS P25774 1/20 0.45
CTSK P43235 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4608578 1.00 ALDH1A1 (0.56) ALDH1A1ACECA2MMEGPR34
SCHEMBL4608581 1.00 ALDH1A1 (0.56) ALDH1A1ACECA2MMEGPR34
SCHEMBL30118364 0.95 ALDH1A1 (0.52) ALDH1A1ACECA2MMEGPR34
SCHEMBL24711923 0.86 NOS2 (0.46) ALDH1A1ACECA2CPA1CA12
SCHEMBL14942929 0.86 NOS2 (0.46) ALDH1A1ACECA2CPA1CA12
SCHEMBL12668881 0.86 NOS2 (0.46) ALDH1A1ACECA2CPA1CA12
SCHEMBL27488809 0.84 MMP1 (0.51) ALDH1A1ACEMMECA12CA7
SCHEMBL6318078 0.84 MMP1 (0.51) ALDH1A1ACEMMECA12CA7
SCHEMBL8373966 0.84 ALDH1A1 (0.57) ALDH1A1ACECA2MMEGPR34
SCHEMBL22290826 0.84 ALDH1A1 (0.57) ALDH1A1ACECA2MMEGPR34

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120071329-A1 METHODS FOR IDENTIFYING COMPOUNDS OF INTEREST USING ENCODED LIBRARIES GLAXOSMITHKLINE LLC (US) 2012-03-22 US disclosed
US-20110251089-A1 METHODS FOR SYNTHESIS OF ENCODED LIBRARIES GLAXOSMITHKLINE (US) 2011-10-13 US disclosed
US-7989395-B2 Methods for identifying compounds of interest using encoded libraries GLAXOSMITHKLINE LLC (US) 2011-08-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110251089-A1 METHODS FOR SYNTHESIS OF ENCODED LIBRARIES RNGTT, DTYMK, DUT ALDH1A1 2470/4885ACE 421/4885CA2 4273/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.